Evonik Industries : Financial Report (260508 Evonik FinancialsQ12026)

About this update from Evonik Industries Ag

Evonik Financials & ESG KPIs Financial KPIs Group P. 2 ESG KPIs P. 3 Segment KPIs P. 4-6 Group Income Statement P. 7-8 Group Balance Sheet P. 9 Group Cash Flow Statement P. 10 Group Net Financial Position P. 11 Definitions P. 12 As of Q1 2025 (published May 08, 2026) Evonik Group Financials in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 External Sales 14,955 18,488 15,267 15,157 3,777 3,499 3,391 3,403 14,069 3,427 Growth (%) 23% 24% -17% -1% -1% -11% -12% -5% -7% -9% Volumes (%) 11% -4% -8% 4% 2% -4% -6% 2% -2% -2% Prices 12% 18% -3% -2% -2% -1% -1% -2% -1% -1% Exchange Rates -2% 5% -2% -1% 1% -3% -3% -5% -2% -5% Other (incl. M&A) 2% 5% -4% -2% -2% -3% -2% 0% -2% -1% Adjusted EBITDA 2,383 2,490 1,656 2,065 560 509 448 357 1,874 475 Margin 15.9% 13.5% 10.8% 13.6% 14.8% 14.5% 13.2% 10.5% 13.3% 13.9% EBIT 1,173 942 -243 577 299 236 -25 68 578 229 Adjusted EBIT 1,338 1,350 521 1,027 309 250 197 105 861 235 Margin 8.9% 7.3% 3.4% 6.8% 8.2% 7.1% 5.8% 3.1% 6.1% 6.9% Adjusted EPS 2.12 2.26 0.79 1.67 0.59 0.34 0.27 0.15 1.36 0.34 Free Cash Flow 950 785 801 873 195 -211 300 411 695 183 Cash Conversion Rate 1 40% 32% 48% 42% 37% Capex (Cash outflow for investment in intangible assets, pp&e) 865 865 793 840 190 176 181 201 748 224 Capital employed (annual average) 14,799 16,192 15,406 14,493 14,038 ROCE 9.0% 8.3% 3.4% 7.1% 6.1% Dividend 1.17 € 1.17 € 1.17 € 1.17 € 1.00 € Employees (continuing operations) 33,004 34,029 33,409 31,930 31,585 31,273 31,297 31,053 31,053 30,643 1 Free cash flow conversion = FCF / adj. EBITDA Evonik Group Environment, Social & Governance KPIs Full set of ESG KPIs published seperately on our IR website: evonik.finance/investor-relations 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY Strategy & Growth Sales share with "Next Generation Solutions" 41% 43% 43% 45% 48% Governance & Compliance Training rate fighting money laundering 96% 97% 98% 99% 100% Training rate antitrust law 83% 85% 89% 90% 91% Training rate fighting corruption 92% 91% 86% 95% 96% Training rate code of conduct 89% 89% 92% 96% 97% Training rate Human Rights (new in 2024) 90% 84% 94% Training rate Data security (new in 2025) 98% Value Chain & Products Procurement volume (in € billion) 10.4 13.6 11.3 10.5 9.8 Production output (million metric tons) 9.5 8.4 7.5 7.3 6.0 Use of renewable raw materials in production 9.7% 11.1% 12.0% 9.0% 10.0% Raw material suppliers covered by TfS assessments 69% 66% 67% 71% 86% No. of sustainability audits (Evonik/TfS) 284 378 492 596 605 No. of sustainability assessments (Evonik/TfS) 1,345 1,545 1,296 1,309 926 R&D expenses (€ million) 464 461 443 459 418 The environment Scope 1 greenhouse gas emissions (thousands metric tons CO 2 ) 4,381 a 4,221 a 3890 b 3,390 2.99 Scope 2 greenhouse gas emissions (thousands metric tons CO 2 ) 1,916 a 1,757 a 1400 b 1,670 1.36 Scope 3 greenhouse gas emissions (million metric tons CO 2 ) 23.4 20.5 a 18.9 b 21.6 19.5 % Reduction in greenhouse gas emissions Scope 1 & 2 (million metric tons CO 2 ) vs base year -43 -5 c -15 c -20 -31 Total water intake (in million m³) 462 d 444 d 403 431 427 Specific water intake (in m³ freshwater / metric ton production) 26.8 d 29.5 d 29.9 32.2 36.7 Production waste (thousand metric tons) 342 d 335 d 287 306 272 Specific production waste (in ton of waster per metric ton production) 0.036 0.04 0.038 0.042 0.045 Employees Early employee turnover 2.2% 1.9% 2.2% 1.7% 5.3% Continuing professional development per employee (hours) 5 4 4 2 2.1 Women at level "Executives" (circle 1) 17.7% 20.3% 22.2% 21.8% 21% Women at level "Senior management" (circle 2) 17.6% 17.1% 18.5% 19.1% 22% Women in management (circle 3) 28.7% 29.9% 30.3% 31.4% 32% Women in management (circles 1-3) 27.9% 29.1% 29.6% 30.7% 32% Safety Occupational health performance index 5.6 5.5 5.5 5.5 5.6 Accident frequency rate (no. of accidents / working hours) b 0.19 0.25 0.21 0.14 0.18 Incident frequency rate (no. of accidents / working hours) b 0.48 0.49 0.43 0.44 0.44 a: adjusted figures corresponding to GHG Protocal Standards | b: Correction of data based on methodological improvements | c: for new target period 2021-2030 | d: data corrected for fast-close proces s (for ESG KPI definitions please see separate "Definitions" page at the end of the file) Custom Solutions in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Sales 5,357 6,568 5,608 5,737 1,427 1,367 1,340 1,359 5,492 1,334 Growth (yoy) 19% 23% -15% 2% 3% -7% -9% -3% -4% -7% Volumes 14% -3% -11% 5% 2% -5% -8% 0% -3% -3% Prices 5% 13% 1% -2% 0% 1% 1% 1% 1% 0% Exchange Rates -1% 5% -3% -1% 1% -3% -3% -5% -3% -6% Other (incl. M&A) 1% 8% -2% 0% 0% 0% 1% 1% 1% 2% Sales Additives 3,588 4,523 3,747 3,908 974 942 899 868 3,683 920 Volumes (%) + - - + = - - - - - Prices (%) + + = - = = = = = = Sales Care 1,768 2,045 1,861 1,829 453 425 441 491 1,809 414 Volumes (%) + = - = + - - + = - Prices (%) + + + = - = + + = = Adjusted EBITDA 1,086 1,162 852 978 256 254 215 184 909 227 Margin 20.3% 17.7% 15.2% 17.0% 17.9% 18.6% 16.0% 13.5% 16.6% 17.0% EBITDA yoy Additives + + - + + - - = - - EBITDA yoy Care + + - - + - - + + - EBIT 558 170 189 120 74 553 152 Adjusted EBIT 663 181 180 140 104 602 152 Capital expenditures 311 50 78 72 100 300 64 Approx. Operating FCF 600 44 112 172 314 642 40 Capital employed (annual average) 6,192 6,054 ROCE 10.7% 9.9% Employees 9,736 9,746 9,649 9,644 - 9,529 9,805 2019-2023 figures pro-forma (unaudited) Approx. Operating FCF provided as simplified indication only (unaudited). Calculated as adj. EBITDA, plus/minus NWC change, minus capex. Not including taxes, provisions and other items, thus not adding up to Group FCF. For sales (volume and price) and EBITDA trends yoy ("+" or "-" in case of >2% deviation; otherwise "=") Advanced Technologies in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Sales 5,827 7,092 5,983 6,089 1,601 1,511 1,445 1,415 5,973 1,450 Growth (yoy) 17% 22% -16% 2% 6% -1% -6% -6% -2% -9% Volumes 11% -3% -8% 2% 6% 1% -2% 2% 2% -1% Prices 8% 20% -4% 0% -3% -1% -1% -3% -2% -1% Exchange Rates -2% 5% -4% -1% 1% -4% -3% -5% -3% -6% Other (incl. M&A) 0% 0% 0% 1% 2% 3% 0% 0% 1% -1% Sales Organics 1,681 1,868 1,742 1,664 426 401 411 395 1,634 390 Volumes (%) + - - + + - + + + = Prices (%) + + = - - = - - - - Sales Inorganics 2,357 3,031 2,491 2,490 621 614 595 566 2,395 577 Volumes (%) + = - + = - - = = - Prices (%) + + = - = = = - = = Sales Animal Nutrition 1,789 2,193 1,750 1,935 554 496 439 454 1,944 484 Volumes (%) + - = = + + - = + + Prices (%) + + - + - - - - - - Adjusted EBITDA 1,233 1,207 752 1,023 291 266 202 186 944 241 Margin 21.2% 17.0% 12.6% 16.8% 18.2% 17.6% 14.0% 13.1% 15.8% 16.6% EBITDA yoy Organics + = - - + - - - - + EBITDA yoy Inorganics + + - + - = - + - + EBITDA yoy Animal Nutrition + - - + + + - - - - EBIT 517 183 137 65 60 445 125 Adjusted EBIT 565 181 150 89 71 492 129 Capital expenditures 367 56 82 72 132 342 60 Approx. Operating FCF 513 156 85 182 250 673 135 Capital employed (annual average) 7,018 6,907 ROCE 8.1% 7.1% Employees 9,568 9,405 9,312 9,189 - 9,177 9,458 2019-2023 figures pro-forma (unaudited) Approx. Operating FCF provided as simplified indication only (unaudited). Calculated as adj. EBITDA, plus/minus NWC change, minus capex. Not including taxes, provisions and other items, thus not adding up to Group FCF. For sales (volume and price) and EBITDA trends yoy ("+" or "-" in case of >2% deviation; otherwise "=") Infrastructure (SYNEQT + Oxeno businesses 1 ) / Other in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Sales Infrastructure & Other 3,771 4,827 3,675 3,331 749 621 606 629 2,604 643 Sales Infrastructure 3,146 708 584 574 583 2,449 577 Sales Other 185 41 37 32 46 155 66 Adjusted EBITDA Infrastructure & Other 96 124 54 64 13 -11 31 -13 21 7 Adj. EBITDA Infrastructure 275 61 38 54 59 213 47 Adj. EBITDA Other -211 -48 -49 -23 -72 -192 -40 EBIT -316 -641 -611 -498 -54 -90 -210 -66 -420 -48 Adjusted EBIT -228 -224 -296 -201 -53 -80 -32 -67 -233 -46 Capital expenditures 292 241 189 138 27 25 29 50 130 21 Employees 16,116 16,504 16,184 12,626 12,434 12,347 11,380 1 Infrastructure is comprised of two distinct businesses 1) SYNEQT = infrastructure assets in Marl and Wesseling and 2) Oxeno = C4 value chain in Marl and Antwerp Group Income Statement in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Sales 14,955 18,488 15,267 15,157 3,777 3,499 3,391 3,403 14,069 3,427 Cost of sales -10,925 -14,257 -12,567 -11,419 -2,769 -2,568 -2,775 -2,714 -10,825 -2,563 Gross profit on sales 4,030 4,231 2,700 3,738 1,008 931 616 689 3,244 864 Selling expenses -1,717 -2,035 -1,836 -1,894 -454 -434 -420 -428 -1,736 -419 Research and development expenses -464 -460 -443 -459 -106 -105 -104 -102 -418 -94 General administrative expenses -546 -554 -488 -740 -126 -125 -111 -113 -474 -114 Other operating income & expenses -138 -252 -186 -89 -25 -33 -7 13 -52 -9 Result from investments recognized at equity 8 12 10 21 2 2 1 9 14 1 Income before financial result and income taxes, cont. ops. = EBIT 1,173 942 -243 577 299 236 -25 68 578 229 Financial Result -88 -19 -108 -143 -29 -44 -52 -30 -156 -46 Income before income taxes, continuing operations 1,085 923 -351 434 270 192 -77 38 422 183 Income taxes -316 -369 -101 -194 -34 -68 -25 -18 -145 -54 Income after taxes, continuing operations 769 554 -452 240 236 124 -102 20 277 129 Income after taxes, discontinued operations -2 1 - 0 0 0 0 0 0 0 Income after taxes 767 555 -452 240 236 124 -102 20 277 129 thereof attributable to non-controlling interests 21 15 13 18 3 4 4 2 12 4 Shareholders of EVONIK Industries AG (net income) 746 540 -465 222 233 120 -106 18 265 125 EPS 1.60 1.16 -1.00 0.48 0.50 0.26 -0.23 0.04 0.57 0.27 Group Adjusted Income Statement in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Sales 14,955 18,488 15,267 15,157 3,777 3,499 3,391 3,403 14,069 3,427 Adjusted EBITDA 2,383 2,490 1,656 2,065 560 509 448 357 1,874 475 Adjusted depreciation and amortization -1,045 -1,140 -1,135 -1,038 -251 -259 -251 -252 -1,013 -240 Adjusted EBIT 1,338 1,350 521 1,027 309 250 197 105 861 235 Adjusted net financial result -97 -19 -103 -143 -29 -44 -52 -37 -162 -46 Adjusted D&A on intangible assets 162 169 153 144 34 32 33 32 131 32 Adjusted income before income taxes 1,403 1,500 571 1,028 314 238 178 100 830 221 Adjusted income taxes, continuing operations -396 -431 -188 -233 -36 -74 -46 -28 -184 -59 Adjusted income after taxes 1,007 1,069 383 795 278 164 132 72 646 162 Adjusted non-controlling interest -21 -15 -13 -18 -3 -4 -4 -1 -12 -4 Adjusted net income 986 1,054 370 777 275 160 128 71 634 158 Adjusted EPS 2.12 2.26 0.79 1.67 0.59 0.34 0.27 0.15 1.36 0.34 Adjustments in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Restructuring measures -32 -121 -64 -405 -12 7 -31 -6 -42 -4 Acquisitions and divestments -29 40 -237 -34 -11 4 0 -7 -14 0 Other special items -104 -327 -463 -11 13 -25 -191 -24 -227 -2 = Adjustments -165 -408 -764 -450 -10 -14 -222 -37 -283 -6 Adjustment categories changed as of December 31, 2023 to avoid overlaps between categories; prior year figures restated Group Balance Sheet Assets in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 FY 2026 Q1 Intangible assets 6,045 5,710 5,525 5,571 5,426 5,176 5,131 5,097 5,122 Property, plant and equipment 6,963 6,962 6,294 6,450 6,305 6,127 5,933 6,006 6,051 Right of use assets (capitalized leasing) 608 972 965 947 905 867 893 892 867 Investments recognized at equity 81 88 52 49 51 45 45 45 46 Trade accounts receivable 67 54 1 1 Financial assets 581 441 460 467 424 455 418 419 397 Deferred tax assets 1,755 890 642 664 629 624 659 436 430 Other income tax assets 16 19 20 25 24 22 22 22 22 Other non-financial assets 125 64 78 69 110 71 87 96 90 Non-current assets 16,174 15,146 14,036 14,242 13,874 13,454 13,242 13,014 13,026 Inventories 2,548 2,820 2,349 2,662 2,751 2,649 2,555 2,300 2,429 Other income tax assets 199 98 209 166 138 103 86 94 95 Trade accounts receivable 1,954 1,898 1,607 1,622 1,732 1,625 1,581 1,525 1,728 Other non-financial assets 382 517 373 381 440 377 363 333 378 Financial assets 571 610 381 216 574 467 266 220 212 Cash and cash equivalents 456 645 749 461 733 379 454 495 589 Current assets 6,110 6,588 5,668 5,508 6,368 5,600 5,305 4,967 5,431 Assets held for sale 0 76 236 0 0 0 0 0 0 Current assets 6,110 6,664 5,904 5,508 6,368 5,600 5,305 4,967 5,431 Total assets 22,284 21,810 19,940 19,750 20,242 19,054 18,547 17,981 18,457 Liabilities in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 FY 2026 Q1 Issued capital 466 466 466 466 466 466 466 466 466 Reserves 8,823 10,508 8,444 8,554 8,719 8,028 7,883 7,644 7,764 Equity attributable to shareholders of Evonik Industries AG 9,289 10,974 8,910 9,020 9,185 8,494 8,349 8,110 8,230 Equity attributable to non-controlling interests 83 82 76 80 82 65 64 64 68 Total equity 9,372 11,056 8,986 9,100 9,267 8,559 8,413 8,174 8,298 Provisions for pensions and other post-employment benefits 3,766 1,359 1,858 1,662 1,449 1,383 1,387 1,490 1,547 Other provisions 657 542 517 734 734 651 667 591 597 Deferred tax liabilities 628 661 608 638 633 625 629 576 592 Other income tax liabilities 195 246 268 254 258 268 246 228 231 Financial liabilities 3,531 4,117 3,502 3,162 3,629 3,586 3,663 3,476 3,471 Other payables 143 182 153 141 97 109 95 118 122 Non-current liabilities 8,920 7,107 6,906 6,591 6,800 6,622 6,687 6,479 6,560 Other provisions 892 732 606 923 955 695 724 787 818 Other income tax liabilities 211 189 124 87 86 63 59 58 79 Financial liabilities 477 429 1,153 1,034 941 1,215 830 689 684 Trade accounts payable 2,022 1,735 1,521 1,600 1,702 1,440 1,359 1,401 1,521 Other payables 390 501 457 415 491 460 475 393 497 Current liabilities 3,992 3,586 3,861 4,059 4,175 3,873 3,447 3,328 3,599 Liabilities associated with assets held for sale 0 61 187 0 0 0 0 0 0 Current liabilities 3,992 3,647 4,048 4,059 4,175 3,873 3,447 3,328 3,599 Total equity and liabilities 22,284 21,810 19,940 19,750 20,242 19,054 18,547 17,981 18,457 Group Cash Flow Statement in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2025 FY 2026 Q1 Income before financial result and income taxes, continuing operations = EBIT 1,173 942 -243 577 299 236 -25 68 578 229 Depreciation, amortization, impairment losses/reversal of impairment losses on non-current a 1,073 1,568 1,841 1,117 240 260 428 275 1,203 239 Result from investments recognized at equity -8 -12 -10 -21 -2 -3 0 -9 -14 -1 Gains/losses on disposal of non current assets 43 -50 -1 22 15 4 5 -13 11 -2 Change in inventories -675 -270 310 -297 -140 7 94 259 220 -104 Change in trade accounts receivable -449 42 105 21 -143 -16 52 112 5 -183 Change in trade accounts payable and current advance payments received from customers 680 -257 -157 74 185 -228 -67 -32 -142 187 Change in provisions for pensions and other post-employment benefits 83 -19 -55 -48 -4 -13 -28 -4 -49 -8 Change in other provisions 207 -149 -141 535 37 -341 40 10 -254 27 Change in miscellaneous assets/liabilities -23 10 152 -81 -100 78 7 -6 -21 46 Cash inflows from dividends 19 19 25 27 0 19 0 7 26 0 Tax payments relating to carve-out of the methacrylates business - - - - - - - - - - Cash inflows/outflows for income taxes -308 -174 -232 -213 -2 -38 -25 -55 -120 -23 Cash flow from operating activities, continuing operations 1,815 1,650 1,594 1,713 385 -35 481 612 1,443 407 Cash flow from operating activities, discontinued operations 0 0 0 0 0 0 0 0 0 0 Cash flow from operating activities 1,815 1,650 1,594 1,713 385 -35 481 612 1,443 407 Cash outflows for investments in intangible assets, property, plant and equipment, investment -865 -865 -793 -840 -190 -176 -181 -201 -748 -224 Cash outflows for investments in shareholdings -85 -27 -76 -15 0 0 -1 0 0 0 Cash outflows for loss from divestments of shareholdings -145 97 -32 -13 0 -1 0 0 -2 0 Cash outflows from divestments of businesses and other shareholdings -21 - -5 -6 0 0 0 0 0 0 Cash inflows from divestments of intangible assets, property, plant and equipment, investmen 9 5 15 21 8 0 1 12 21 10 Cash inflows for loss from divestments of shareholdings 2 - 43 16 3 6 0 9 18 0 Cash inflows for investments in shareholdings 2 0 2 1 0 10 13 4 Cash inflows/outflows relating to securities, deposits and loans 23 -3 161 137 -352 199 164 -4 8 3 Cash inflows from interest 12 16 32 37 18 7 6 5 38 4 Cash flow from investing activities, continuing operations -1,070 -777 -653 -663 -511 36 -11 -169 -652 -203 Cash flow from investing activities, discontinued operations 0 0 0 0 0 0 0 0 0 0 Cash flow from investing activities -1,070 -777 -653 -663 -511 36 -11 -169 -652 -203 Cash inflows/outflows relating to capital contributions 0 0 0 0 1 3 0 0 4 0 Cash outflows for dividends to shareholders of Evonik Industries AG -536 -545 -545 -545 - -545 0 0 -545 0 Cash outflows for dividends to non-controlling interests -21 -13 -10 -20 -1 -4 -4 -1 -10 -2 Cash infows/outflows from changes in ownership interests in subsidiaries without loss of cont 0 -5 - 0 0 -19 0 0 -19 0 Cash outflows for the purchase of treasury shares -15 -16 -16 -12 0 -1 0 0 -1 0 Cash inflows from the sale of treasury shares 12 12 12 9 0 1 0 0 1 0 Cash inflows from the addition of financial liabilities 655 1,649 716 708 521 308 921 97 1,833 71 Cash outflows for repayment of financial liabilities -948 -1,577 -893 -1,354 -107 -79 -1,252 -485 -1,909 -172 Cash inflows/outflows in connection with financial transactions 91 -104 12 -7 2 5 0 11 16 20 Cash outflows for interest -94 -73 -99 -109 -14 -12 -53 -22 -101 -29 Cash flow from financing activities, continuing operations -856 -672 -823 -1,330 402 -343 -388 -400 -731 -112 Cash flow from financing activities, discontinued operations 0 0 0 0 0 0 0 0 0 0 Cash flow from financing activities -856 -672 -823 -1,330 402 -343 -388 -400 -731 -112 Change in cash and cash equivalents -111 201 118 -280 276 -342 82 43 60 92 Cash and cash equivalents as of beginning of period 563 456 645 749 461 735 379 454 461 495 Change in cash and cash equivalents -111 201 118 -280 276 -342 82 43 60 92 Changes in exchange rates and other changes in cash and cash equivalents 4 -12 -14 -8 -3 -14 -7 -2 -26 2 Cash and cash equivalents as of end of period 456 645 749 461 734 379 454 495 495 589 Cash and cash equivalents included in assets held for sale 0 0 0 0 0 0 0 0 0 0 Cash and cash equivalents as on the balance sheet as of end of period 456 645 749 461 734 379 454 495 495 589 Group Net Financial Position in € million 2021 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2025 Q2 2025 Q3 2025 FY 2026 Q1 Non-current financial liabilities -3,527 -4,074 -3,320 -2,961 -3,429 -3,393 -3,482 -3,314 -3,285 Current financial liabilitites -232 -243 -1,006 -883 -845 -1,136 -771 -617 -562 Financial debt -3,759 -4,317 -4,326 -3,844 -4,274 -4,529 -4,253 -3,931 -3,847 - Cash and cash equivalents 456 645 749 461 733 379 454 495 589 - Current securities 446 413 261 128 482 285 121 124 117 - Other financial assets 0 2 6 2 1 1 1 1 1 Financial assets 902 1,060 1,016 591 1,216 665 576 620 707 Net financial debt/cash as stated on the balance sheet -2,857 -3,257 -3,310 -3,253 -3,058 -3,864 -3,677 -3,311 -3,140 Net financial debt/cash, discontinued operations - - - 0 0 0 0 0 0 Net financial debt/cash including discontinued operations -2,857 -3,257 -3,310 -3,253 -3,058 -3,864 -3,677 -3,311 -3,140 Financial KPI Definitions Adjusted EBIT Earnings before financial result and taxes, after adjustments. Earnings indicator showing Evonik's operating earnings performance irrespective of the structure of its assets. Adjusted EBITDA Earnings before financial result, taxes, depreciation and amortization, after adjustments. Earnings indicator showing Evonik's operating earnings performance irrespective of the structure of its assets and its investment profile. This is a cash flow-related indicator which is used in particular in the adjusted EBITDA margin to show the relationship to sales as a basis for comparison with competitors. Adjusted net income We use adjusted net income to assess the earnings power of the continuing operations, especially on a long-term view, and to forecast future development. The calculation starts from EBITDA after adjustment for special items. The financial result is then adjusted for income and expenses in connection with the acquisition/divestment of shareholdings and other income and expense items that, by nature or amount, do not form part of typical current financing activities. Further, we deduct amortization of intangible assets, as they mainly result from acquisitions, and adjust income tax for taxes on special items. Adjustments Evonik refers to the special items that are factored out when calculating the operational performance indicators adjusted EBITDA and adjusted EBIT as adjustments. They include restructuring, impairment losses/reversals of impairment losses, income and expenses in connection with the purchase/disposal of investments in companies, and other income and expense items that, due to their nature or amount, do not reflect the typical operating business. Free Cash Flow The free cash flow is a measure of the company's internal financing capacity. It shows the cash that is available to pay dividends, make acquisitions and repay borrowing. The free cash flow is calculated from the cash flow from operating activities, continuing operations, less outflows for capital expenditures on intangible assets, property, plant and equipment. ROCE The return on capital employed is a measure of the profitability of capital employed. It is calculated by dividing adjusted EBIT by the average capital employed in the reporting period. ESG KPI Definitions Value added in € million We use an impact valuation to regularly measure and analyze the direct and indirect impacts from an economic, ecological, and social perspective. This supplements our established analytical approaches. We anticipate that this will allow early identification of potential future opportunities and risks, make our business model more resilient, and improve understanding of the long-term value that our business activities create for society. We aim to assign a monetary value to individual indicators such as continuing development of employees, employment impacts, and global warming so they can be compared. Most of the factors used for this are publicly available. Sales share with "Next Generation Solutions" Sales share of products with superior sustainability benefits to customers ("Next Generation Solutions"); derived from sustainability analysis of our businesses based on the principles and content of the WBCSD Portfolio Sustainability Assessments (PSA) For more information please see Evonik website: Responsibility - Value Chain & Products - Sustainability Analysis Internal Investigations Internal investigations are initiated when there is a suspected violation of compliance rules (including the code of conduct, antitrust law and the rules on fighting and preventing corruption). Since 2018, the scope of reporting has covered all internal investigations in the Evonik Group. Before that, only the areas covered by the House of Compliance were included. Disciplinary Measures Disciplinary measures are taken as a result of an internal investigation. A disciplinary measure can result in an employee's dismissal, warning or reprimand, transfer to a different position or further awareness enhancement. In rare cases, legal proceedings (civil or criminal) had to be initiated. Raw Material Suppliers Covered by TfS Assessments This number indicates how many raw material suppliers have been covered by TfS assessments in that year. The chemical industry set up the Together for Sustainability (TfS) initiative in 2011 with the goal to harmonize global standards in the supply chain to create transparency and make it easier for both suppliers and customers to reliably assess and evaluate sustainability performance. This includes assessing the suppliers' quality, grade of environmental protection, safety, health, energy management, the assessment of potential risk factors. Evonik is one of the founding members of this initiative. Greenhouse Gas Emissions Scope 1: Evonik's direct energy and process-related emissions; Scope 2: Purchased energy (net, total purchased power and steam - sale of power and steam to third parties; market-based approach); Scope 3: Indirect emissions, including emissions from the production of purchased raw materials, packaging materials, capital goods, energy-related emissions outside scopes 1 and 2, emissions from inbound shipments of raw materials, from the disposal of production waste, business trips, commuting by employees, Evonik's fleet of vehicles, enregy requierements for offices and emissions from the disposal and recycling of products sold. Early Employee Turnover Turnover of newly hired employees within the first year of employment Management circles/ levels Management circle 1 = executive functions, i.e., top management functions in the Evonik Group Management circle 2 = senior management functions, i.e., key functions in the divisions, regions, service units, and corporate functions Management circle 3 = further management functions Occupational Health Performance Index This index shows the extent to which internal requirements have been implemented and goals achieved. It is calculated from two parameters from each of the following areas: occupational medicine, health promotion and emergency medical management. Both the quality and the scope of the measures are taken into account. The index is calculated annually. Specific water intake in m 3 freshwater per metric ton production Freshwater usage in relation to production. Total water intake Evonik's consumption of freshwater is the total of drinking water, groundwater, surface water, and recycled water. Total water intake is the sum of total freshwater and salt water (sea water). Page

View stock analysis, news, and events for Evonik Industries Ag